Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could ...

Eli Lilly and Co LLY on Thursday issued a public warning about potential safety risks linked to compounded tirzepatide ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Eli Lilly warns risks of compounded tirzepatide with B12 due to impurities that may cause toxicity and immune reactions, urging patient caution.

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

Eli Lilly warns compounded tirzepatide mixed with B12 may contain impurities and safety risks as FDA tightens GLP-1 rules—get the latest updates now.

By Leah Douglas WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ...

Shares of Eli Lilly and Company (NYSE:LLY) slipped about 1% in early Thursday trading after the drugmaker cautioned about potential safety concerns tied to compounded versions of tirzepatide mixed ...

Eli Lilly says testing found impurities, bacterial contamination and endotoxin in compounded tirzepatide mixtures with vitamin B12 and other additives.

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Hims & Hers (HIMS) shares dropped 16% after-hours as FDA plans to restrict compounded GLP-1 ingredients and HHS referred Hims to DOJ. Hims projected $725M in weight-loss revenue for 2025 from total ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...